These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 1612871
1. [Are the publicized advantages of thrombolytic treatment of myocardial infarct with recombinant t-PA (ACTILYSE) in comparison with streptokinase so decisive, that despite the high cost a general use of ACTILYSE is justified?]. Gulba DC. Internist (Berl); 1992 May; 33(5):364-5. PubMed ID: 1612871 [No Abstract] [Full Text] [Related]
2. [Actilyse (a recombinant tissue-type plasminogen activator] in the treatment of acute myocardial infarct. Comparison of the effects of Actilyse and streptokinase]. Bastecký J, Kvasnicka J, Macek K, Malý J, Rozsíval V, Chrobák L, Gajdosová I, Skopecková H, Wasylivová V, Ettlerová E. Vnitr Lek; 1994 May; 40(5):293-8. PubMed ID: 8023469 [Abstract] [Full Text] [Related]
4. Is the use of t-PA as compared with streptokinase cost effective? Rose EA. N Engl J Med; 1995 Oct 12; 333(15):1009; author reply 1010. PubMed ID: 7666904 [No Abstract] [Full Text] [Related]
5. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective]. Lorenzoni R, Fattore G, Gensini G. G Ital Cardiol; 1997 Jul 12; 27(7):721-6. PubMed ID: 9303862 [Abstract] [Full Text] [Related]
8. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]. Verstraete M, Bory M, Collen D, Erbel R, Lennane RJ, Mathey D, Michels HR, Schartl M, Uebis R, Bernard R. Klin Wochenschr; 1988 Jul 12; 66 Suppl 12():77-85. PubMed ID: 3126348 [Abstract] [Full Text] [Related]
10. Early patency in acute myocardial infarction. Belenkie I. Can J Cardiol; 1993 Mar 12; 9(2):149-51. PubMed ID: 8490781 [No Abstract] [Full Text] [Related]
11. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W, Schmutzler H. Herz; 1994 Dec 12; 19(6):336-52. PubMed ID: 7843690 [Abstract] [Full Text] [Related]
17. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)]. Cannas S, De Leo A, Marzari A. G Ital Cardiol; 1997 Mar 12; 27(3):278-80. PubMed ID: 9244730 [Abstract] [Full Text] [Related]